Results 101 to 110 of about 7,468,951 (263)

Perspectives on noble metallenes: from synthesis to application [Elektronisk resurs]

open access: yes
Metallenes are presented for a new class of single-atom-thick two-dimensional (2D) metal sheets. It is motivated by a recent (2024) discovery of 2D gold, dubbed goldene, by selectively etching off Ti3C2 slabs from a Ti3AuC2 nanolaminate.
Rosén, Johanna   +7 more
core   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Silicon-integrated diodes made with solution-processed 2D materials

open access: yes
Printed electronics based on two-dimensional (2D) materials provides a scalable and low-cost approach to device fabrication, enabling mask-free patterning and low-temperature processing.
Casiraghi C.   +6 more
core   +1 more source

Decoding the structure of interfaces and impurities in 2D materials by photoelectron holography

open access: yes, 2019
The properties of atomically thin materials essentially depend on their structures, including impurities, defects and interfaces with underlying substrates.
Usachov D. Y.   +55 more
core   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Preface: Two dimensional (2D) hybrid organic-inorganic perovskites

open access: yes, 2018
2D hybrid organic-inorganic perovskites (HOIPs) have been intensively investigated over the past 30 years before the rise of photovoltaic 3D hybrid perovskites.
Docampo, Pablo   +7 more
core   +1 more source

Electronic and Optical Properties of Two-Dimensional Tellurene: From First-Principles Calculations

open access: yesNanomaterials, 2019
Tellurene is a new-emerging two-dimensional anisotropic semiconductor, with fascinating electric and optical properties that differ dramatically from the bulk counterpart.
David K. Sang   +6 more
doaj   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Strain-displacement relations for strain engineering in single-layer 2d materials

open access: yes, 2016
We investigate the electromechanical coupling in single-layer 2d materials. For non-Bravais lattices, we find important corrections to the standard macroscopic strain-microscopic atomic-displacement theory.
Midtvedt, Daniel   +8 more
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy